Epoetin alfa - PDFSEARCH.IO - Document Search Engine

Epoetin alfa
Results: 69

#	Item
1	Considerations on WHO’s BQ Proposal Joerg Windisch, PhD, Chair European Biosimilars Group (EBG) Chief Science Officer, Sandoz Biopharmaceuticals 60th INN Consultation WHO, Geneva, April 13th, 2015 Add to Reading List Source URL: www.egagenerics.com Language: English - Date: 2015-04-13 04:15:44 Information Erythropoiesis-stimulating agents Pharmacology Amgen Metadata Pharmacovigilance Epoetin alfa Erythropoietin Identifier Medicine Growth factors Data
2	original article http://www.kidney-international.org & 2008 International Society of Nephrology see commentary on page 695 Add to Reading List Source URL: www.nature.com Language: English - Date: 2008-08-29 06:37:18 Biology Hemoglobins Growth factors Anemias Amgen Erythropoietin Epoetin alfa Hematocrit Blood Medicine Hematology Erythropoiesis-stimulating agents
3	27-JUN6t34 DEPT OF HERLTH ffitE €!fgt[$ Add to Reading List Source URL: www.hkam.org.hk Language: English - Date: 2014-02-19 00:50:59 Pharmacology Biology Erythropoietin Epoetin alfa Darbepoetin alfa Epoetin beta Adverse drug reaction Methoxy polyethylene glycol-epoetin beta Continuous erythropoietin receptor activator Erythropoiesis-stimulating agents Medicine Growth factors
4	WEB-ONLY CONTENT The Impact of Selecting a High Hemoglobin Target Level on Health-Related Quality of Life for Patients With Chronic Kidney Disease A Systematic Review and Meta-analysis Add to Reading List Source URL: archinte.jamanetwork.com Language: English Growth factors Erythropoietin Epoetin alfa Chronic kidney disease Darbepoetin alfa Epoetin beta Dialysis Renal failure Kidney Medicine Erythropoiesis-stimulating agents Biology
5	asbmbnews Retrospective: Eugene Goldwasser (1922 – 2010) BY NICOLE KRESGE E Add to Reading List Source URL: www.asbmb.org Language: English - Date: 2011-03-25 10:10:26 Biology Pharmacology Amgen Erythropoietin Eugene Goldwasser Darbepoetin alfa Epoetin alfa Goldwasser Anemia Erythropoiesis-stimulating agents Medicine Growth factors
6	HEMATOPOIETIC AGENTS CRITERIA Pharmacology: Erythropoietin is a glycoprotein which stimulates red blood cell production. It is produced in the kidney and stimulates the division and differentiation of committed erythroid Add to Reading List Source URL: www.nhhealthyfamilies.com Language: English - Date: 2014-09-11 16:48:46 Biology Anemias Amgen Erythropoietin Epoetin alfa Darbepoetin alfa Myelodysplastic syndrome Peginesatide Hematide Medicine Erythropoiesis-stimulating agents Growth factors
7	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Mircera safely and effectively. See full prescribing information for Mircera. Mircera (methoxy polyethylene glyco Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-10-08 13:53:43 Biology Erythropoietin Darbepoetin alfa Epoetin alfa Anemia Methoxy polyethylene glycol-epoetin beta Chronic kidney disease DAHANCA Continuous erythropoietin receptor activator Erythropoiesis-stimulating agents Medicine Growth factors
8	Passport Health Plan Prior Authorization Procrit® Note: Form must be completed in full. An incomplete form may be returned. Information on this form is protected health information and subject to all privacy and securit Add to Reading List Source URL: www.passporthealthplan.com Language: English - Date: 2014-03-31 16:26:10 Anemias Hematopathology B vitamins Chemotherapy Epoetin alfa Folic acid Darbepoetin alfa Vitamin B12 Medicine Erythropoiesis-stimulating agents Growth factors
9	Updates to the Alberta Human Services Drug Benefit Supplement Effective July 1, 2014 Inquiries should be directed to: Add to Reading List Source URL: www.ab.bluecross.ca Language: English - Date: 2014-06-27 12:34:29 Pharmacology Biology Clopidogrel Darbepoetin alfa Erythropoietin Syringe Pharmaceutical drug Voriconazole Epoetin alfa Medicine Erythropoiesis-stimulating agents Growth factors
10	Date Dear Physician I am writing to make you aware that the Public Employees Insurance Agency (PEIA) will be implementing a “Procrit® First” policy for treating patients with anemia effective May 1, 2009. Epoetin a Add to Reading List Source URL: www.peia.wv.gov Language: English - Date: 2012-11-27 15:02:48 Biology Pharmacology Erythropoietin Darbepoetin alfa Epoetin alfa Anemia Medical prescription ALFA Peginesatide Erythropoiesis-stimulating agents Medicine Growth factors

UPDATE